Editorial Board — Medscape Infectious Diseases

Board Members

  • Loren G. Miller, MD, MPH
    • Harbor-UCLA Medical Center
      Torrance, California
  • Kogieleum K. Naidoo, MBChB
    • Senior Scientist, Head of TB HIV Treatment Research Programme
      Centre for the AIDS Programme of Research in South Africa (CAPRISA)
      Nelson R. Mandela School of Medicine
      University of KwaZulu-Natal, Durban
      KwaZulu-Natal, South Africa
  • Paul A. Offit, MD
    • University of Pennsylvania School of Medicine
      The Children's Hospital of Philadelphia
      Philadelphia, Pennsylvania
  • Jan E. Patterson, MD
    • University of Texas Health Science Center
      South Texas Veterans Health Care System
      San Antonio, Texas
  • Robert C. Read, MBChB, MD, FRCP
    • Southampton University Medical School
      Southampton General Hospital
      Southampton, United Kingdom
 

Board Member Details

Paul G. Auwaerter, MD
Paul G. Auwaerter, MD

Professor of Medicine, John Hopkins University School of Medicine; Clinical Director, Division of Infectious Diseases, Johns Hopkins Hospital, Baltimore, Maryland

Paul G. Auwaerter, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: bioMerieux

John G. Bartlett, MD
John G. Bartlett, MD

Professor Emeritus, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland

JJohn G. Bartlett, MD, has disclosed no relevant financial relationships.

Helen W. Boucher, MD
Helen W. Boucher, MD

Associate Professor of Medicine, Division of Geographic Medicine and Infectious Diseases; Director, Infectious Diseases Fellowship Program, Tufts University School of Medicine, Boston, Massachusetts

Helen W. Boucher, MD, has disclosed the following relevant financial relationships: Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: TheraDoc (Hospira, Inc.); American Board of Internal Medicine; Basilea Pharmaceutica Ltd.; Merck & Co., Inc.; Paratek; Rib-X; Theravance, Inc.

John Boyce, MD
John Boyce, MD

John Boyce, MD, JM Boyce Consulting, LLC, Middletown, Connecticut

John Boyce, MD, has disclosed the following relevant financial relationships:
Serve(d) as an advisor or consultant for: 3M Company; GOJO Industries; Clorox Company
Plan to serve as consultant to Diversey Care in 2016
Recent (2014-2015) research support from Diversey Care, previously Virox Company

Received income in an amount equal to or greater than $250 from: 3M Company; GOJO Industries; Clorox Company

Matthew E. Falagas, MD, MSc, DSc
Matthew E. Falagas, MD, MSc, DSc

Director, Alfa Institute of Biomedical Sciences, Athens, Greece; Adjunct Associate Professor of Medicine, Tufts University School of Medicine, Boston, Massachusetts

Matthew E. Falagas, MD, MSc, DSc,has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: AstraZeneca Pharmaceuticals LP
Serve(d) as a speaker or member of a speakers bureau for: Angelini; Astellas Pharma, Inc.; AstraZeneca Pharmaceuticals LP; Merck &Co., Inc; Pfizer Inc.

Loren G. Miller, MD, MPH
Loren G. Miller, MD, MPH

Associate Professor of Medicine; Director, Infection Care Program, Department of Infectious Diseases, Harbor-UCLA Medical Center, Torrance, California

Loren G. Miller, MD, MPH, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Durata Therapeutics
Received research grant from: GlaxoSmithKline; Merck & Co, Inc.; Cerexa; Gilead Sciences, Inc.

Kogieleum K. Naidoo, MBChB
Kogieleum K. Naidoo, MBChB

Kogieleum K. Naidoo, MBChB, Senior Scientist, Head of TB HIV Treatment Research Programme, Centre for the AIDS Programme of Research in South Africa (CAPRISA), Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa

Kogieleum K. Naidoo, MBChB, has disclosed the following relevant financial relationships:
Serve(d) as a speaker or a member of a speakers bureau for: Gilead Sciences, Inc.
Received research grant from: US Centers for Disease Control and Prevention; US Agency for International Development; National Institutes of Health
Received income in an amount equal to or greater than $250 from: Centre for the AIDS Programme of Research in South Africa; Gilead Sciences, Inc.

Paul A. Offit, MD
Paul A. Offit, MD

Professor, Department of Pediatrics, Division of Infectious Diseases, Perelman School of Medicine, University of Pennsylvania; Attending Physician, Department of Pediatrics, Division of Infectious Diseases, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania

Paul A. Offit, MD, has disclosed no relevant financial relationships.

Jan E. Patterson, MD
Jan E. Patterson, MD

Professor, Department of Medicine, Divisions of Infectious Diseases and Pathology; Associate Dean for Quality and Lifelong Learning, University of Texas Health Science Center; Staff Physician, University Health System and South Texas Veterans Health Care System, San Antonio, Texas

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Society for Healthcare Epidemiology; American Board of Internal Medicine, Infectious Diseases Subspecialty Board Received research grant from: University of Texas System; Institute for Healthcare Improvement; Pfizer Inc Received income in an amount equal to or greater than $250 from: American Board of Internal Medicine, Infectious Diseases Subspecialty Board

Robert C. Read, MBChB, MD, FRCP
Robert C. Read, MBChB, MD, FRCP

Professor, Infection and Immunity, Southampton University Medical School; Consultant Physician, Southampton General Hospital, Southampton, United Kingdom

Robert C. Read, MBChB, MD, FRCP, has disclosed no relevant financial relationships.